Financial reports
10-K
2023 FY
Annual report
26 Mar 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K/A
2022 FY
Annual report (amended)
31 Mar 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
23 May 23
8-K
Changes in Registrant's Certifying Accountant
21 Feb 23
8-K/A
Entry into a Material Definitive Agreement
22 Nov 22
8-K
Entry into a Material Definitive Agreement
22 Nov 22
8-K
Departure of Directors or Certain Officers
21 Oct 22
8-K
Departure of Directors or Certain Officers
13 Sep 22
8-K
Departure of Directors or Certain Officers
4 Jan 22
8-K
Other Events
24 Nov 20
8-K
Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018
27 Apr 18
8-K
Departure of Directors or Certain Officers
14 Feb 18
Registration and prospectus
D
$600K in equity, sold $35K, 2 investors
7 Dec 18
D/A
$700K in equity, sold $660.41K, 4 investors
20 Sep 17
D
$400K in equity, sold $45K, 1 investor
14 Sep 17
D
$700K in equity, sold $300K, 1 investor
2 Feb 17
D
$30K in equity, sold $2.5K, 1 investor
19 Aug 15
D
$30K in equity, sold $30K, 1 investor
21 Apr 15
D/A
$171.5K in equity, sold $164K, 3 investors
2 Sep 14
D/A
$171.5K in equity, sold $134K, 2 investors
28 May 14
D
$121.5K in equity, sold $121.5K, 2 investors
1 May 14
D/A
$130K in equity, sold $130K, 1 investor
1 May 14
Ownership